• Follow
  • Follow
  • Follow
  • Follow
Global Sunshine Reporting for HCP Engagement, US and Italian Transparency Reporting, Sunshine Laws, and Pharmaceutical Compliance
  • La Legge
  • Eventi
  • Risorse
    • Notizie
    • Blog
    • Partner di Compliance Consigliati
    • Link Utili
  • Chiedi a un Esperto
  • Domande Frequenti (FAQ)
  • Informazioni
  • Contattaci
MYISR
Countdown to Sanità Trasparente: What U.S. Compliance Teams Must Know

Countdown to Sanità Trasparente: What U.S. Compliance Teams Must Know

by Sabrina Morgan | Nov 5, 2025 | en

Tradurre in Italiano Countdown to Sanità Trasparente: What U.S. Compliance Teams Must Know Table of content Current Status and Timeline Challenges and Pitfalls The Executive Perspective: Strategic Considerations Practical Implementation: Your Roadmap Conclusion Author...
From Rome to the World: How Italian Transparency Obligations Extend Internationally

From Rome to the World: How Italian Transparency Obligations Extend Internationally

by May Khan | Oct 21, 2025 | en

Tradurre in Italiano From Rome to the World: How Italian Transparency Obligations Extend Internationally Table of content Italian HCPs Interacting with Foreign Companies Foreign Professionals Operating in Italy Italian HCPs Abroad Cross-Border Research and Trials...
5 Common Mistakes to Avoid in First-Year Sunshine Reporting

5 Common Mistakes to Avoid in First-Year Sunshine Reporting

by Sabrina Morgan | Oct 16, 2025 | en

Tradurre in Italiano 5 Common Mistakes to Avoid in First-Year Sunshine Reporting Table of content 1. Overlooking the Importance of Detailed “Nature of Spend” Categorization 2. Duplicate and Overlapping Transactions 3. Misaligned Reporting Periods 4. Currency and Value...
The Role of an Intermediary or Third-Party Under the Italian Sunshine Act

The Role of an Intermediary or Third-Party Under the Italian Sunshine Act

by May Khan | Oct 2, 2025 | en

Tradurre in Italiano The Role of an Intermediary or Third-Party Under the Italian Sunshine Act Table of content Intermediaries: Broader Than You Think Responsibility Rests With the Company Navigating Corporate Complexity Industry Guidance vs. Ministry Expectations...
France’s Loi Bertrand vs. Italy’s Sunshine Act: Similarities and Divergences

France’s Loi Bertrand vs. Italy’s Sunshine Act: Similarities and Divergences

by May Khan | Sep 26, 2025 | en

Tradurre in Italiano France’s Loi Bertrand vs. Italy’s Sunshine Act: Similarities and Divergences Table of content Similarities Between France and Italy’s Sunshine Laws Key Differences Between French and Italian Sunshine Acts The French Anti-Gift Law: Another...
Non-Reportable Transfers of Value: 10 Scenarios You Don’t Need to Disclose Part 2/2

Non-Reportable Transfers of Value: 10 Scenarios You Don’t Need to Disclose Part 2/2

by Mauro Teresi | Sep 16, 2025 | en

Tradurre in Italiano Non-Reportable Transfers of Value: 10 Scenarios You Don’t Need to Disclose Part 2/2 Table of content 1. Donations to non-health NGOs 2. Patient education materials co-developed with HCPs 3. AI-based diagnostic tools for pilot use 4. Institutional...
« Older Entries
Next Entries »

Recent Posts

  • Sunshine Act: non riguarda solo le Pharma. Riguarda tutto l’ecosistema salute.
  • Sunshine Act – EFPIA vs. Italian Regulatory Framework
  • Sunshine Act – EFPIA vs. Quadro Normativo Italiano
  • Submitting to Sanità Trasparente with Confidence: What “XML Readiness” Really Means
  • Invio a Sanità Trasparente con sicurezza: cosa significa davvero essere “pronti” in XML

Recent Comments

  1. Esiah Ehrnrooth on Transparency Consultation Update: Insights into Italy’s Telematic Register
  2. A WordPress Commenter on Transparency Consultation Update: Insights into Italy’s Telematic Register

La Legge

Notizie

Eventi

 

Risorse

Chiedi a un Esperto

Domande Frequenti (FAQ)

 

Informazioni

Contattaci

  • Follow
  • Follow
  • Follow
  • Follow

© 2026 Italian Sunshine Reporting. All Rights Reserved.